TNF and rheumatoid arthritis: Clinically, some TNF inhibitors, including adalimumab, are prescribed for RA patients in combination with the immunosuppressant MTX to prevent the formation of ADAs (12, 13), but a number of patients are unable to tolerate MTX because of its side effects (14).